Formosa Laboratories Inc. | Ownership
Companies that own Formosa Laboratories Inc.
Dimensional Fund Advisors LP
1,934,863
1.98%
220,648
0%
04/30/2018
Reliance Securities Investment Trust Co., Ltd.
549,216
0.56%
27,686
1.87%
03/31/2018
BNY Mellon Asset Management North America Corp.
401,109
0.41%
0
0%
09/06/2018
Royce & Associates LP
275,810
0.28%
-66,044
0%
06/30/2018
Deutsche Far Eastern Asset Management Co., Ltd.
206,586
0.21%
983
0.46%
03/31/2018
QS Investors LLC
48,141
0.05%
0
0%
03/29/2018
Dimensional Fund Advisors Ltd.
9,049
0.01%
9,049
0%
11/30/2017
Mercer Global Investments Europe Ltd.
9,027
0.01%
9,027
0%
12/31/2017
Bessemer Investment Management LLC
7,021
0.01%
0
0%
04/30/2018
Goldman Sachs Asset Management LP
6,018
0.01%
0
0%
04/30/2018
| Address |
No. 36 Hoping Street
Taoyuan 338 42
Taiwan
|
|
Employees
|
- |
| Website |
http://www.formosalab.com |
| Updated |
07/08/2019 |
| Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. It specializes in development, production, process, and sale of ultraviolet absorbers, cholesterol phosphate binders, vitamin D derivatives, anti-inflammatory analgesic, and central nervous system drugs. The company's products include active pharmaceutical ingredients, contract research and custom synthesis, integrated application delivery controller services, and ultraviolet filters for sunscreens and cosmetics. |
